Health
Nuvectis Pharma Announces Upcoming Presentations For NXP900 At The 2024 AACR-NCI-EORTC Symposium On Molecular Targets And Cancer Therapeutics
(MENAFN - GlobeNewsWire - Nasdaq) Fort Lee, NJ, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company ...
By: menafn
- Oct 23 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS